2016
Correlation of body mass index with female survival benefit among a single-institution cohort of cutaneous melanomas >1 mm thick following wide-local excision and sentinel lymph node biopsy.
Jackson L, Bulloch K, Narayan D, Ariyan S, Gould Rothberg BE. Correlation of body mass index with female survival benefit among a single-institution cohort of cutaneous melanomas >1 mm thick following wide-local excision and sentinel lymph node biopsy. Journal Of Clinical Oncology 2016, 34: 172-172. DOI: 10.1200/jco.2016.34.3_suppl.172.Peer-Reviewed Original ResearchBody mass indexDisease-free survivalWide local excisionCutaneous melanomaSurvival benefitSentinel lymphMass indexNormal-weight menNormal-weight womenSingle-institution cohortCox proportional hazardsNon-therapeutic interventionsFree survivalSLN statusWeight womenClinicopathologic factorsConsecutive patientsLocal excisionMultivariable analysisWeight menLifestyle factorsActive surveillanceSimilar survivalSurvival advantageMitotic count
2014
Red meat and fruit intake is prognostic among patients with localized cutaneous melanomas more than 1mm thick
Rothberg BE, Bulloch K, Fine J, Barnhill R, Berwick M. Red meat and fruit intake is prognostic among patients with localized cutaneous melanomas more than 1mm thick. Cancer Epidemiology 2014, 38: 599-607. PMID: 25194935, PMCID: PMC4229370, DOI: 10.1016/j.canep.2014.08.005.Peer-Reviewed Original ResearchConceptsMelanoma-specific survivalLocalized cutaneous melanomaFruit consumptionPost-diagnostic measuresDaily fruit consumptionModifiable lifestyle behaviorsRed meatBreslow thicknessCutaneous melanomaAssociated with melanoma-specific survivalRed meat consumptionAssociated with worse outcomesSurvivorship periodLifestyle behaviorsCancer survivorsPhysical activityTobacco cessationFruit intakeNon-therapeutic interventionsTime of diagnosisCox proportional hazardsHigh fish consumptionDietary choicesIndex melanomaIndependent associations
2013
Marginal and Joint Distributions of S100, HMB-45, and Melan-A Across a Large Series of Cutaneous Melanomas
Viray H, Bradley WR, Schalper KA, Rimm DL, Rothberg BE. Marginal and Joint Distributions of S100, HMB-45, and Melan-A Across a Large Series of Cutaneous Melanomas. Archives Of Pathology & Laboratory Medicine 2013, 137: 1063-73. PMID: 23899062, PMCID: PMC3963468, DOI: 10.5858/arpa.2012-0284-oa.Peer-Reviewed Original ResearchConceptsHMB-45Primary tumorCutaneous melanomaLarge seriesMelanoma-specific survivalMelanoma primary tumorsGroup of antigensLarge tissue microarrayClinicopathologic covariatesClinicopathologic criteriaPrognostic relevanceHistopathologic profileClinicopathologic correlatesAntigen expressionClinicopathologic parametersMelanoma markersTissue microarrayPositive expressionSurvival analysisMelanomaMelanS100Melanoma cellsBivariate associationsSignificant differences
2009
Tissue Biomarkers for Prognosis in Cutaneous Melanoma: A Systematic Review and Meta-analysis
Rothberg BE, Bracken MB, Rimm DL. Tissue Biomarkers for Prognosis in Cutaneous Melanoma: A Systematic Review and Meta-analysis. Journal Of The National Cancer Institute 2009, 101: 452-474. PMID: 19318635, PMCID: PMC2720709, DOI: 10.1093/jnci/djp038.Peer-Reviewed Original ResearchConceptsCohort studyCutaneous melanomaMelanoma cell adhesion moleculeSystematic reviewEarly-stage cutaneous melanomaPotential prognostic valueMatrix metalloproteinase-2Cell nuclear antigenREMARK criteriaAdjuvant therapyMultivariable analysisREMARK guidelinesRisk stratificationPrognostic valueSurvival outcomesIncomplete adherenceMelanoma outcomesClinical managementImmunohistochemical expressionCell adhesion moleculeInclusion criteriaKi-67Tissue biomarkersClinical practiceMetalloproteinase-2